NorthWest Biotherapeutics Inc (NWBO)

[Hopeforthefuture3]

Goodguybill, aree with some of what you posted but not all
1 yes they did complete the trial but way later than most here predicted. Results were solid but not 'spectacular' at median nearly 3 month improvement in OS. 13% 5 year survival better than double accepted averages - very good but far lower than what was expected on this board. I regularly got roasted for posting 20%-25% 5 year survival
2the did release tld at NYAS but was handled very poorly by nwbo PR department. Should have had a PR touting a couple good items as summary tld with more to come with full paper - they did not and shareholders suffered
3 flaskworks is hardly a done deal as at asm was still in design and testing mode - submission is based on manual method which imo is fine for now
4i agree I think they have the patents
5 they did eventually get to the finish line but imo years late. Data lock in 2020 yet SAP took way long and only 1 submission by end of 2023, may get 1 approval in 2024(I hope) but could take into 2025 (this on MHRA I believe unless nwbo is slow on answering questions) in 2015 nwbo was listed on NASDAQ worth 1 billion in market cap with under 100 millions shares outstanding. Now on otc, 1.2 billion shares and mc of 350 million. Don't think they are going to bankrupt any one nwbo has made it but they are the one in financial difficulties
To me this does not seem like great management but to each their own